Moreover, the increased interaction of RGMb–PD-L2 mediated by PD-1 inhibitors might disrupt the immune tolerance of lung tissue by increasing the vigorous clonal expansion of T cells that reside in the lung and then lead to the occurrence of pneumonitis (118) (Figure 3). This evidence concerns the gene PDCD1 and pneumonitis.